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ABSTRACT 
Benzimidazole is a heterocyclic aromatic organic compound. This bicylic compound consists of the fusion of benzene and imidazole. Benzimidazole in an extention of the well 
elaborated imidazole system has been used as carbon skeleton for N- heterocyclic carbines. A large variety of 2-substituted benzimidazoles have been found to possess antiulcer, 
antihelmenthic anti-inflammatory, antispasmodic, antihistaminic, antimicrobial, anticancer, cycloxygenase inhibitor, and HIV-1 reverse transcriptase inhibitor activities.   
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INTRODUCTION 
All  the  heterocyclic  compounds  have  a  great  interest  in 
pharmaceutical chemistry. Out of these heterocyclic compounds the 
benzfused  heterocyclic  compound  i.e.  Benzimidazole  and  its 
derivatives have wide variety of biological activities, in addition to 
that  the  Benzimidazole  have  played  a  very  important  role  in  the 
development  of  theory  in  heterocyclic  chemistry  and  also 
extensively in organic synthesis.
1 
Benzimidazole  is  an  important  pharmacophore  and  privileged 
structure  in  medicinal  chemistry.  Literature  survey  shows  that 
among the benzimidazole derivatives, 2-substituted ones are found 
to  be  pharmacologically  more  potent  and  hence  the  design  and 
synthesis of 2-substituted benzimidazoles are the potential area of 
research.
2  
Extensive biochemical and pharmacological studies have confirmed 
that  its  derivatives  are  effective  against  various  strains  of 
microorganisms.  The  reason  for  a  special  interest  of  researchers 
toward  benzimidazole  derivatives  has  been  5,6  dimethyl 
benzimidazole which is a constituent of naturally occur ring vitamin 
B12 .Although vitamin B12 is capable of inducing the growth of 
bacteria, the benzimidazole component and some of its derivatives  
repress  the  bacterial  growth.  Due  to  the  structural  similarity  to 
purine, antibacterial ability of benzimidazoles is explained by their 
competition with purines resulting in inhibition of the synthesis of 
bacterial nucleic acids and proteins.
2  
Benzimidazoles drugs are widely used for prevention and treatment 
of  parasitic  infections.  Thiabendazole  (TBZ)  was  the  first 
benzimidazole to be marketed over 40 years ago. It has been used 
widely for control of gastrointestinal nematodes, lungworms and as 
a fungicidal agent. After its introduction, a number of alternative 
benzimidazoles offering similar activity came to the market, such as 
parbendazole  (PAR), cambendazole (CAM), mebendazole (MBZ) 
and  oxibendazole  (OXI).  Benzimidazoles  possessing  sulphide  and 
sulphoxide functional groups were subsequently introduced, offering 
a  wider  spectrum  of  activity  and improved  efficacy.  Albendazole 
(ABZ), fenbendazole (FBZ) and oxfendazole (OFZ) were the first 
such benzimidazoles to be successfully used in the treatment of all 
growth stages of gastrointestinal nematodes. They may be used also 
in the treatment of lungworms, tapeworms and adult stages of liver 
fluke.  The  benzimidazole,  triclabendazole  (TCB)  was  later 
introduced as an antihelmenthic agent for treatment of all stages of 
liver fluke, but it is ineffective against nematodes. Luxabendazole 
(LUX) is another benzimidazole-sulphide used in the treatment of 
food-producing animals but is not licensed for use in the EU. The 
low solubility of benzimidazole sulphides and sulphoxides leads to 
their low absorption from the gut, resulting in low bioavailability. 
Netobimin (NETO) and febantel (FEB),which are the pro-drugs of 
ABZ and FBZ, respectively, have greater water solubility resulting 
in  improved  absorption  and  increased  bioavailability.  Similar 
probenzimidazoles have found widespread use as fungicidal agents, 
including benomyl (BEN) and thiophanate-methyl (TM), which are 
precursors  of  carbendazim  (MBC)  .
COMPOUNDS HAVING BENZIMIDAZOLE NUCLEUS 
As Antiulcer Agents  
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As Anthelmintic Drugs 
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6-Chloro-5-(2,3-dichloro-phenoxy)-2-methylsulfanyl-1H-benzoimidazole
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(6-Phenylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
[Fenbendazole]  
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(6-Propoxy-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
[Oxibendazole]  
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[Oxfendazole]  
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[6-(4-Fluoro-phenylsulfanyl)-1H-benzoimidazol-
2-yl]-carbamic acid methyl ester
[Luxabendazole]  
 
LITERATURE REVIEW  
Chemical Review 
A.K. Tiwari et al. (2005) reported the synthesis of N substituted 2- substituted- benzimidazole. 
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Nagawade et al. (2006) reported the BF3.OEt2 catalyzed synthesis of benzimidazole. 
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Wang Yulu et al. (2007) reported the p-TsOH Catalyzed synthesis of 2-arylsubstituted benzimidazoles. 
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A. Anton Smith et al. (2008) reported the Synthesis of 2, 3-dihydro -2-[1-(4-isobuty1 phenyl) ethyl]-lH benzo[d] Imidazole. 
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2-[1-(4-Isobutyl-phenyl)-ethyl]-1H-benzoimidazole  
Jat Rakesh Kumar et al. (2006) reported the Synthesis of 2-substituted Benzimidazole. 
8 
N
H
N
R
H2N
HNO3
H2SO4
NH2
NH2
N
N
H
R +
R R'
O
o- Phenylenediamine R=Alkyl/Aryl
R'= -OH, Acid  
R'=H, Aldehyde
2-substituted 
Benzimidazole
5-Nitro-2-phenyl 
Benzimidazole  
Mukesh C. Sharma et al. (2010)   reported the Synthesis of (1H-Benzimidazol-2-yl)-phenyl-methanol. 
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Anoop Singh et al. (2010) reported the synthesis of benzimidazole-2-thione. 
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Biological Review 
Antimicrobial Activity 
A. Anton Smith et al. 
 
(2008) reported the synthesis of 2, 3-dihydro-2-[1-(4-isobuty1-phenyl) ethyl]-lHbenzo[d] Imidazole was evaluated for 
its antimicrobial activity against S. aureus, E. coli, P. aeruginosa.
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K.F. Ansari et al. (2009) 
 
reported the synthesis of benzimidazole derivatives having oxadiazole nucleus which shows the antimicrobial 
activity.
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Mishra et al. (2010) 
 
reported the synthesis of novel benzimidazolyl chalcones which shows the antimicrobial activity.
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N1-[4-(1H-benzo[d]imidazol-2yl)phenyl]-(E)-3-phenyl-2propenamide, 
(R=C6H5) 
Mishra et al. (2010) 
 
reported the synthesis of nitro and halogeno-substituted benzimidazole derivatives which shows the antimicrobial 
activity.
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5, 6-Dinitro-1-(2, 3-dihydroxyprop-1-yl) benzimidazole 
N
H
N
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[2-(4,6-Dichloro-1H-benzoimidazol-2-ylsulfanyl)-ethyl]-dimethyl-amine 
Mishra et al. (2010) 
 
reported the synthesis of some novel 5-substituted benzimidazole derivatives which shows the antimicrobial activity.
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R               X                Y                IUPAC Name 
H               -  cyclopentyl  2-Cyclopentyl benzimidazole 
Cl              -  cyclopentyl      5-Chloro-2-cyclopentyl benzimidazole 
H            CH2  cyclopentyl     2-Cyclopentylmethylbenzimidazole 
Cl           CH2         cyclopentyl     5-Chloro-2-cyclopentylmethyl benzimidazole 
H            C2H4       cyclopentyl     2-(2 -Cyclopentylethyl) benzimidazole 
Cl           C2H4       cyclopentyl   5-Chloro-2-(2-cyclopentylethyl) benzimidazole 
H            C2H4       cyclohexyl      5-Chloro-2-(2-cyclohexylethyl) benzimidazole 
 
Gulgun  Ayhan-Kılcıgil  et  al.  (1999)  reported  the  synthesis  of  1-Benzyl-2-(4-benzyloxy-phenyl)-1H-benzoimidazole-5-carboxylic  acid 
methyl ester which shows the antimicrobial activity. 
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Ismail  Yalcın et  al.  (1998) reported  the  synthesis  of  N-[4-(5-Nitro-1H-benzoimidazol-2-ylmethyl)-phenyl]-acetamide  which  shows  the 
antimicrobial activity. 
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Ziya Erdem Koc et al. (2010) reported the synthesis of tripodal-benzimidazoles which shows the antimicrobial activity. 
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Yusuf Ozkay et al. (2010) reported the synthesis of 4-(1H-Benzimidazol-2-yl)-benzoic acid (4-chloro-benzylidene)-hydrazide which shows 
the antimicrobial activity. 
16 
N
H
N
C
O
HN N
Cl
 
Meral Tuncbilek et al. (2009) reported the synthesis of some novel substituted benzimidazole derivatives having potent activity against 
MRSA and also showed antifungal activity. 
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R1          R2          R3               R4                      IUPAC Name 
Cl           H             H             Cyclopentyl  5-Chloro-1-cyclopentyl-1H- 
  benzimidazole 
Cl          Cl             H             Cyclopentyl  5,6-Dichloro-1-cyclopentyl-1H- 
    benzimidazole 
Cl          Cl            Cl             Cyclopentyl  2,5,6-Trichloro-1-cyclopentyl-1H- 
  benzimidazole 
Cl          Cl   NHCH(CH3)2  Cyclopentyl  5,6-Dichloro-1-cyclopentyl-2- 
  (isopropylamino)-1Hbenzimidazole 
Cl          Cl            Br             Cyclopentyl   2-Bromo-5,6-dichloro-1-cyclopentyl- 
  1H-benzimidazole 
Cl          Cl            NH2         Cyclopentyl   2-Amino-5, 6-dichloro-1-cyclopentyl- 
    1H- benzimidazole 
Cl           H            NH2        Cyclopentyl  2-Amino-5-chloro-1-cyclopentyl-1H- 
  benzimidazole 
 
Malleshappa Noolvi et al. (2011) reported the synthesis of antimicrobial and cytotoxic activity of novel azetidine-2-one derivatives of 1H-
benzimidazole. 
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R                                              IUPAC Name                                   
4-Chloro                           3-Chloro-4-(4-chlorophenyl)-1-(1-methyl-1H- 
  benzimidazol- 2-yl) azetidin-2-one  
4-Nitro                             3-Chloro-1-(1-methyl-1H-benzimidazol-2-yl)-4-(4- 
    nitrophenyl) azetidin-2-one  
2-Nitro                             3-Chloro-1-(1-methyl-1H-benzimidazol-2-yl)-4-(2-   
  nitrophenyl) azetidin-2-one  
3-Nitro                             3-Chloro-1-(1-methyl-1H-benzimidazol-2-yl)-4-(3- 
  nitrophenyl) azetidin-2-one  
N,N-dimethyl amino       3-Chloro-4-[4-(dimethylamino) phenyl]-1-(1-methyl- 
  1H-benzimidazol-2-yl) azetidin-2-one  
2,5-dimethoxy                 3-Chloro-4-(2,5-dimethoxyphenyl)-1-(1-methyl-  
  1Hbenzimidazol-2-yl) azetidin-2-one  
2-Chloro                          3-Chloro-4-(2-chlorophenyl)-1-(1-methyl-1H-benzimidazol- 
    2-yl) azetidin-2-one  
Ozden Ozel Guuven et al. (2011) reported the synthesis and antimicrobial activity of some novel phenyl and benzimidazole substituted 
benzyl ethers. 
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    Ar    IUPAC Name 
 
         1-(2-(Benzyloxy)-2-phenylethyl)-1H-benzimidazole           
 
F
    1-(2-(4-Fluorobenzyloxy)-2-phenylethyl)-1H-   
  Benzimidazo 
Cl
   1-(2-(4-Chlorobenzyloxy)-2-phenylethyl)-1H-   
  benzimidazole 
Br
  1-(2-(4-Bromobenzyloxy)-2-phenylethyl)-1H- 
   benzimidazole 
CF3
  1-(2-(4-(Trifluoromethyl)benzyloxy)-2-phenylethyl)- 
  1Hbenzimidazole 
Gulgun Ayhan-Kılcıgil et al. (2006) reported the synthesis of some benzimidazole derivatives and their in vitro antifungal activities were 
tested against Candida albicans, Candida glabrata and Candida krusei. Compounds possessed activity comparable to fluconazole against C. 
albicans with a minimum inhibitory concentration of 12.5 g/mL. 
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R1                        R2            X         IUPAC Name 
 
 C3H7                  H               H        1-Phenyl-3-(2-phenyl-1-propyl-1H-   
    benzimidazol-5-yl)-thiourea  
 C3H7                  F               Cl      1-(4-Chloro-phenyl)-3-[2-(4-fluoro-phenyl)-1-  
  propyl-1H-benzimidazol-5-yl]-thiourea  
  F               H      1-[1-Cyclopenta-1,3-dienyl-2-(4-fluoro-phenyl)- 
  1H-benzimidazol-5-yl]-3-phenyl-thiourea 
  F      Cl       1-(4-Chloro-phenyl)-3-[1-cyclopenta-1,3-dienyl-2- 
  (4- fluoro-phenyl)-1H-benzoimidazol-5-yl]-thiourea 
 
Antiulcer activity 
Brumagniez et al. (2008) reported the synthesis of 2-(thiopropyne) - 5- (imidazole -1-yl.) benzimidazole which exhibited moderate antiulcer 
activity against ulcer induced by anti inflammatory agents in rats orally. 
20 
 
 
 
 
 
 
 
Kovalev et al.  (2008) reported the synthesis of 9-(diethyl amino ethylene) 2 – phenyl imidazo [1, 2-a] benzimidazole, which was found to 
be more potent than omeprazole.  
20 
 
 
 
 
 
 
Keiji Kubo et al. (2008) reported the synthesis of 2-[( 3-methyl , 4- trifluro ethoxy ) 2- pyridyl  methyl , sulfinyl ] benzimidazole which 
showed antisecretory, antiulcer , cytoprotective activity. After examining the pharmacological and toxicological properties Lansoprazole  
was selected as a promising antiulcer agent.
20 
 
 
 
 
 
 
Shimamura et al. (2008) reported 
 the synthesis of 2-[(4-dimethyl amino, 5 carboxylate 2 pyrimidinyl) methyl sulfinyl] benzimidazole in 
which the  pyridine nucleus of  omeprazole is replaced by ethyl 4- dimethyl amino-5- pyrimidine carboxylate showed good antiulcer , 
gastroprotective and antisecretory activity. 
20 
 
 
 
 
 
 
 
Katano et al. 
 
(2008) reported the synthesis of 2 - [(2, 2, 6, 6 tetramethyl piperidine) ethyl thio] 5- methoxy benzimidazole which showed 
moderate activity.   
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Braendstroem et al. (2008) reported the synthesis of 2- [(3, 4 dimethoxy, 2 –pyridyl) methyl, sulfinyl] 5- acetyl, 6-methyl benzimidazole 
which inhibited gastric acid secretion in dogs.
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Sohda et al. (2008) reported the synthesis of 2- [(3-methyl, 4-difluromethoxy, 2-pyridyl) methyl, sulfinyl] benzimidazole inhibited ethanol 
induced ulcers in rats.
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Shin-ichi et al. 
 
(2008) reported the synthesis of 2- [( 4- methoxy , 6,7,8,9- tetra hydro- 5H – cyclohepta pyridine –9-yl ) sulfinyl ] 1-H 
benzimidazole sodium salt  which showed promising antiulcer activity and stability on isolated H
+
/K
+
-ATPase of rabbit gastric mucosa.
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Bernhard et al.  (2008) reported the synthesis of 2-[(difluro methoxy-2-pyridyl) methyl sulfinyl] 5- difluromethoxy benzimidazole was 
highly active against H
+
/K
+
-ATPase.
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Kim et al. (2008) reported the synthesis of 2-[(3-methyl, 4-methoxy, 2-pyridyl) methyl, sulfinyl 5- (1- pyrrolyl) benzimidazole which 
showed moderate activity against H
+
/K
+
ATPase with low toxicity.
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Kohl  et  al.  (2008)  reported  the  synthesis  of  2-[3-methyl,  4  (N-methyl,  1,  2,  4  triazole  3  yl,  1,  3  dithiane)  2  pyridyl  ]  methyl  thio 
benzimidazole  which showed high activity against Helicobacter Pylori.
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Braendstroem et al.
 
(2008) reported the synthesis of Methyl 2- ((3, 4-dimethoxypyridin-2-yl) methylsulfinyl)-6-methyl-1H-benzimidazole-
5-carboxylate which showed high activity in dog & rat.
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Tsukahara et al. (2008) reported the synthesis of 2- (1-H benzimidazole 2-sulfinyl methyl) phenyl isobutyl methyl amine which showed 
good antiulcer activity.
20 
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Yum et al. (2008) 
 
reported the synthesis of 2- [ [ 2,2 dimethyl 2-H pyrrano ( 3,2,c ) 2- pyridyl ] methyl, sulfinyl ] 4- methoxy benzimidazole  
which showed high activity against H
+ 
/ K
+ 
ATPase.
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Shrinivasulu et al. 
 
(2008) reported the synthesis of 2- n propyl, 5 (N methyl 3, 4 cyclo hexane, 4 amino piperidine) keto, 6 ethoxy, 
benzimidazole which exhibited good antiulcer activity.
20 
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Antiviral Activity 
Laila A. Abou-zeid et al. (2008) reported the synthesis of 4-Amino-6-(2-methyl-1H-benzimidazol-5-ylamino)-[1, 3, 5] triazine-2-carboxylic 
acid hydrazide which shows the antiviral activity. 
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A.K.Tiwari et al. (2006) reported the synthesis of 3-(1-Benzyl-1H-benzimidazol-2-yl)-propionic acid which shows the antiviral activity. 
22 
N
N
CH2CH2COOH
CH2C6H5  
J.M. Gardiner et al. (2006) reported the synthesis of 2-Ethyl-4-methyl-1-propoxy-1H-benzimidazole which shows the antiviral activity. 
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Anti-inflammatory activity 
Gummadi  et  al.  (2010)  synthesized  a  series  of  novel  isatinylidene-hydrazinecarboxamide  derivatives  and  evaluated  for  in  vivo 
antiinflammatory activity. 
24 
 
 
 
 
 
 
 
 
Sawhney et al. (1990) synthesized certain 2-(5-aryl-4, 5-dihydropyrazol-3-yl)-  and 2-(2-amino-6-arylpyrimidin-4-yl)benzimidazoles and 
screened  them for antiinflammatory activity.
25 
N
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N
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R
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R=H ,NO2; R1= H, CH3 
R2= C6H5,4-CH3C6H5, 4-CH3OC6H4,4-ClC6H4 
Antihypertensive activity 
Jat  Rakesh  Kumar  et  al.  (2006) reported  the  synthesis of  4'-(5-Amino-2-phenyl-benzimidazol-1-ylmethyl)-biphenyl-2-carboxylic  acid 
which shows the antihypertensive activity. 
8 
N
N
COOH
H2N
 
Mukesh C. Sharma et al. (2010) reported the synthesis of 4'-[5-Amino-2-(amino-phenyl-methyl)-benzoimidazol-1-ylmethyl]-biphenyl-2-
carboxylic acid which evaluated for nonpeptide angiotensin II receptor antagonist.
26 
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